Virtual drug trials boost results
Bringing drug trials to the virtual realm, Belinda Tan ’96 has found a way to cut entire process in half.
Bringing drug trials to the virtual realm, Belinda Tan ’96 has found a way to cut entire process in half.
New fellowship program honoring trailblazing Nobel laureate awards four MIT postdocs focused on drug discovery and development.
A fascination with magic leads Institute Professor Robert Langer to solve world problems using the marvels of chemical engineering.
Human tissue samples linked by microfluidic channels replicate interactions of multiple organs.
MIT biological engineers discover why a promising drug failed in clinical trials.
New cancer research initiative eyes individualized treatment for patients.
Platform connects individual pieces of lab equipment, compiles data in the cloud for speedier, more accurate research.
Replacing daily pills with a weekly regimen could help patients stick to their dosing schedule.
Continuous-flow chemistry device used for drug production could find use in long-duration space missions.
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease.
New strategy could enable existing drugs to kill bacteria that cause chronic infections.
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
Studies by Richard Wurtman have led to development of nutrient mix shown to slow cognitive impairment in early stages of the disease.
Microparticles created by new 3-D fabrication method could release drugs or vaccines long after injection.
MIT affiliates recognized for their innovative approaches to energy storage and drug discovery.